ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 315 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,080 | +34.3% | 524 | +78.2% | 0.00% | – |
| Q2 2023 | $10,484 | +40.4% | 294 | 0.0% | 0.00% | – |
| Q1 2023 | $7,468 | -37.4% | 294 | 0.0% | 0.00% | – |
| Q4 2022 | $11,925 | +19.2% | 294 | 0.0% | 0.00% | – |
| Q3 2022 | $10,000 | 0.0% | 294 | 0.0% | 0.00% | – |
| Q2 2022 | $10,000 | -9.1% | 294 | +25.6% | 0.00% | – |
| Q1 2022 | $11,000 | -47.6% | 234 | -27.6% | 0.00% | – |
| Q4 2021 | $21,000 | +40.0% | 323 | +38.0% | 0.00% | – |
| Q3 2021 | $15,000 | -21.1% | 234 | 0.0% | 0.00% | – |
| Q2 2021 | $19,000 | +18.8% | 234 | 0.0% | 0.00% | – |
| Q1 2021 | $16,000 | -11.1% | 234 | 0.0% | 0.00% | – |
| Q4 2020 | $18,000 | +80.0% | 234 | 0.0% | 0.00% | – |
| Q3 2020 | $10,000 | 0.0% | 234 | 0.0% | 0.00% | – |
| Q2 2020 | $10,000 | +11.1% | 234 | -22.5% | 0.00% | – |
| Q1 2020 | $9,000 | -40.0% | 302 | +29.1% | 0.00% | – |
| Q4 2019 | $15,000 | +114.3% | 234 | 0.0% | 0.00% | – |
| Q3 2019 | $7,000 | +250.0% | 234 | +185.4% | 0.00% | – |
| Q1 2019 | $2,000 | – | 82 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |